trospium chloride 30 MG / xanomeline 125 MG Oral Capsule [Cobenfy]
RxNorm concept 2694855, branded drug (sbd). Prescribable name: COBENFY 125 MG / 30 MG Oral Capsule.
- RxCUI
- 2694855
- Term type
- Branded drug (SBD)
- Status
- Active
curl https://api.healthcare.dev/v1/drugs/rxnorm/2694855 \ -H "Authorization: Bearer $HDEV_API_KEY"
Concept
Ingredients and related concepts
Ingredients
Other names
Cobenfy (trospium chloride 30 MG / xanomeline 125 MG) Oral Capsule; Cobenfy 125 MG / 30 MG (equivalent to xanomeline tartrate 191.7 MG / trospium 27.5 MG) Oral Capsule
Related concepts
- trospium chloride 30 MG (SCDC, consists of)
- xanomeline 125 MG (SCDC, consists of)
- trospium chloride 30 MG / xanomeline 125 MG [Cobenfy] (SBDC, consists of)
- Oral Capsule (DF, has dose form)
- Cobenfy (BN, has ingredient)
- trospium chloride 30 MG / xanomeline 125 MG Oral Capsule (SCD, tradename of)
Linked data
NDCs
NDC-11s RxNorm links to this concept; linked ones open their FDA product.
Use it
Look up 2694855 from code or an agent
curl https://api.healthcare.dev/v1/drugs/rxnorm/2694855 \ -H "Authorization: Bearer $HDEV_API_KEY"
Using the healthcare.dev MCP server, look up RxNorm concept 2694855. Tell me its name and term type, its ingredients and related concepts, and the NDCs linked to it.
Source: U.S. National Library of Medicine, release 2026-10-05. No license required (Current Prescribable Content). Reference data, not medical advice.